ENDRA Life Sciences Inc. ( NDRA) - Key Metrics
NDRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $0.12 | -$0.70 | -$0.71 |
| 2026Q1 | $0 | -$1.09 | -$0.93 | -$0.93 |
| 2025Q4 | $0 | -$4.03 | -$2.05 | -$5.86 |
| 2025Q3 | $0 | -$2.10 | -$1.53 | -$1.53 |
| 2025Q2 | $0 | -$1.71 | -$1.55 | -$1.55 |
NDRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 11.10 |
| 2026Q1 | 0% | -1.07 |
| 2025Q4 | 0% | -0.35 |
| 2025Q3 | 0% | -0.64 |
| 2025Q2 | 0% | -0.51 |
NDRA
Price: $6.05
52 week price:
Earnings Per Share: -6.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 4700
Ebitda: -2.3 millionMarket Capitalization: 5.7 million